Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1CNS 1

Conditions

Solitary Pulmonary Nodule 1Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Cigarette Smoking 1Brain Neoplasms 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Drug Therapy 219Cyclophosphamide 219Paclitaxel 205apatinib 201Bevacizumab 196camrelizumab 190Fluorouracil 188sintilimab 133Irinotecan 125Blood Specimen Collection 125Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 112Pemetrexed 108anlotinib 105S 1 (combination) 105Leucovorin 102Surveys and Questionnaires 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × OTHER × 4-fluoroglutamine × Clear all
NCT03721055 2019-09-06

Fluoroglutamine PET/CT in Imaging Patients With Malignant Tumor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Phase NA Unknown
60 enrolled
CNS

Brain Neoplasms, Neoplasm Metastasis, Neoplasms

NCT03568799 2018-10-19

GLN

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Phase NA Unknown
30 enrolled
Thoracic

Cigarette Smoking, Solitary Pulmonary Nodule, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡